期刊
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
卷 47, 期 6, 页码 666-684出版社
WALTER DE GRUYTER GMBH
DOI: 10.1515/CCLM.2009.159
关键词
clinical proteomics; mass spectrometry; profiling; tumor
Proteomics analysis has been heralded as a novel tool for identifying new and specific biomarkers that may improve diagnosis and monitoring of various disease states. Recent years have brought a number of proteomics profiling technologies. Although proteomics profiling has resulted in the detection of disease-associated differences and modification of proteins, current proteomics technologies display certain limitations that are hampering the introduction of these new technologies into clinical laboratory diagnostics and routine applications. In this review, we summarize current advances in mass spectrometry based biomarker discovery. The promises and challenges of this new technology are discussed with particular emphasis on diagnostic perspectives of mass-spectrometry based proteomics profiling for malignant diseases. Clin Chem Lab Med 2009;47:666-84.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据